Solute Carrier Family 29 (Nucleoside Transporters), Member 1 (SLC29A1) Peptid
SLC29A1
Reaktivität: Human
Wirt: Synthetic
BP, BI
-
- Target Alle SLC29A1 Produkte
- SLC29A1 (Solute Carrier Family 29 (Nucleoside Transporters), Member 1 (SLC29A1))
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), BioImaging (BI)
- Produktmerkmale
- ENT1 peptide corresponds to 13 amino acids of ENT1.
-
-
- Applikationshinweise
- ENT1 peptide is used for blocking the activity of ENT1 antibody . The ENT1 antibody ships at 0.5 mg/mL and the STK36 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide..
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- ENT1 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
- Target
- SLC29A1 (Solute Carrier Family 29 (Nucleoside Transporters), Member 1 (SLC29A1))
- Synonyme
- ENT1 Peptide, rENT1 Peptide, 1200014D21Rik Peptide, AA407560 Peptide, solute carrier family 29 member 1 (Augustine blood group) Peptide, solute carrier family 29 member 1 Peptide, solute carrier family 29 (nucleoside transporters), member 1 Peptide, SLC29A1 Peptide, Slc29a1 Peptide
- Gen-ID
- 2030
- NCBI Accession
- NP_001071643
- OMIM
- 9296956
- UniProt
- Q99808
-
Sie sind hier:
